Akebia Therapeutics Inc
NASDAQ:AKBA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
A
|
Ares Capital Corp
XHAM:9A2
|
US |
|
Monroe Capital Corp
NASDAQ:MRCC
|
US |
Shareholder Yield
Current shareholder yield for
AKBA is
.
Peers Comparison
Shareholder Yield
Price Appreciation
AKBA Price
Akebia Therapeutics Inc
| Average Annual Return | 12.72% |
| Standard Deviation of Annual Returns | 79.56% |
| Max Drawdown | -94% |
| Market Capitalization | 273.3m USD |
| Shares Outstanding | 267 880 000 |
| Percentage of Shares Shorted | 10.45% |